whats in tirzepatide for Weight Loss (Fat Loss) Expert GLP-1 Tirzepatide Weight Loss

You should not use this medicine if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that offers powerful glycemic control and weight reduction through once-weekly subcutaneous injection

Over time, poorly controlled blood sugar increases the risk of cardiovascular disease, nephropathy, retinopathy, and neuropathy

Saxenda, one brand of liraglutide, was discontinued by the manufacturer at the end of 2025

Growth hormone secretagogues offer potential solutions